Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/25/2851748/0/en/SAB-Biotherapeutics-Announces-Clinical-Partnership-with-Naval-Medical-Research-Center-to-Advance-Potential-Influenza-Treatment.html
https://www.globenewswire.com//news-release/2024/02/23/2834429/0/en/SAB-Biotherapeutics-to-Present-at-the-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/08/2825949/0/en/SAB-Biotherapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/02/02/2822787/0/en/SAB-Biotherapeutics-Announces-Executive-Leadership-Change.html
https://www.globenewswire.com//news-release/2024/01/23/2814588/0/en/SAB-Biotherapeutics-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html
https://www.globenewswire.com//news-release/2024/01/02/2802947/0/en/SAB-Biotherapeutics-Announces-1-for-10-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2023/11/29/2787640/0/en/SAB-Biotherapeutics-Announces-Commencement-of-the-HUMAN-Phase-1-Clinical-Trial-with-SAB-142-a-Potential-Disease-Modifying-Treatment-for-Type-1-Diabetes.html
https://www.globenewswire.com/news-release/2023/11/20/2783145/0/en/SAB-Biotherapeutics-Appoints-Katie-Ellias-to-the-Board-of-Directors.html
https://www.globenewswire.com//news-release/2023/11/14/2779962/0/en/SAB-Biotherapeutics-Announces-Completion-of-67-1-Million-Financing-to-Advance-Potential-Disease-Modifying-Treatment-for-Type-1-Diabetes.html
https://www.globenewswire.com//news-release/2023/11/14/2779939/0/en/SAB-Biotherapeutics-Announces-Q3-2023-Financial-Results-and-Provides-Company-Updates.html